Examqo

Examqo › Examqo library › Geriatric medicine › Assessment, pharmacology and hospital care · IMLE

Frailty and sarcopenia

Frailty is a state of reduced reserve across many systems in which a small event (an infection, a new drug, an operation) causes a large drop in function; sarcopenia is loss of muscle strength and mass, and treatment of both rests on resistance exercise and adequate protein.

Why it matters in the exam

The exam asks about the definitions: the Fried phenotype with its five criteria (3 or more = frail, 1–2 = pre-frail), the Clinical Frailty Scale (1–9) and the frailty index based on accumulated deficits. A common question is the treatment: resistance exercise is the best-proven intervention.

For sarcopenia (EWGSOP2, 2019) candidates need to know that strength comes before mass: low grip strength raises suspicion ("probable sarcopenia"), low muscle mass confirms it, and poor performance (gait speed of 0.8 m/s or less) defines severe disease. Frailty also predicts complications after surgery and chemotherapy, so it is part of the assessment before a treatment decision.

In clinical questions frailty appears as an older woman who has lost weight, is tired, walks slowly and struggles to open a jar, and candidates are asked for the first intervention — a tailored exercise programme and protein-rich nutrition, together with a medication review. They are also asked about the prognostic meaning: a frail person undergoing surgery is at high risk of delirium, complications and moving into an institution, so frailty assessment is part of the goals-of-care discussion. Frailty is a dynamic state — pre-frailty can improve with intervention.

Key points

Summary table

ConceptDefinitionValues for the exam
Fried phenotypeWeight loss, exhaustion, low activity, slow gait, weak grip3 or more = frail; 1–2 = pre-frail
Clinical Frailty ScaleClinical rating 1–95 or more = frail
Frailty indexProportion of deficits from a listAbout 0.25 or more = frail
Probable sarcopeniaLow grip strength or slow chair riseGrip below 27 kg in men, below 16 kg in women
Confirmed and severe sarcopeniaLow muscle mass (DXA); severe = also poor performanceGait speed 0.8 m/s or less
TreatmentResistance training, protein, treat contributing causesProtein 1.0–1.2 g/kg/day; no approved drug

In the full version for subscribers

The full version is open to subscribers of: Geriatrics, Medical licensing exam (IMLE), Internal medicine, Family medicine, Physical medicine and rehabilitation.

Subscriber? Read the full topic Plans and prices 25 free questions

Sources

Sources are given for further reading; the text is written afresh and not copied from them.

Reviewed by the Examqo AI Professor · 2026-11-06. The text may contain errors; when in doubt, check the source.